Search research articles
Contact Us
Filters
Showing results (501-510 of 635) with videos related to
Page
of 64
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 2, 2021
Reply
Ikuo Hirano, Margaret H Collins, David A Katzka, et al.
Gastrointestinal Endoscopy
|
September 20, 2021
Wide-area transepithelial sampling for dysplasia detection in Barrett's esophagus: a systematic review and meta-analysis
D Chamil Codipilly, Apoorva Krishna Chandar, Kenneth K Wang, et al.
Biotechnology Progress
|
September 3, 2014
Agrobacterium tumefaciens mediated transient expression of plant cell wall-degrading enzymes in detached sunflower leaves
Sang-Kyu Jung, Benjamin E Lindenmuth, Karen A McDonald, et al.
Gut
|
September 21, 2011
Association of insulin and insulin-like growth factors with Barrett's oesophagus
Katarina B Greer, Cheryl L Thompson, Lacie Brenner, et al.
Translational Oncology
|
February 19, 2010
Evidence for DNA damage checkpoint activation in barrett esophagus
Urs von Holzen, Tina Chen, Amelie Boquoi, et al.
The American Journal of Gastroenterology
|
September 28, 2000
CagA-positive strains of Helicobacter pylori may protect against Barrett's esophagus
M F Vaezi, G W Falk, R M Peek, et al.
Gut
|
February 6, 2015
Barrett's oesophagus length is established at the time of initial endoscopy and does not change over time: results from a large multicentre cohort
Fouad J Moawad, Patrick E Young, Srinivas Gaddam, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 15, 2025
Long-term Safety and Efficacy of Budesonide Oral Suspension for Eosinophilic Esophagitis: A 4-Year, Phase 3, Open-Label Study
Evan S Dellon, David A Katzka, Vincent A Mukkada, et al.
Therapeutic Advances in Gastroenterology
|
December 30, 2024
Effect of randomized treatment withdrawal of budesonide oral suspension on clinically relevant efficacy outcomes in patients with eosinophilic esophagitis: a post hoc analysis
Evan S Dellon, Margaret H Collins, David A Katzka, et al.
Gastro Hep Advances
|
May 28, 2026
Development and Validation of a Large Language Model Case Identification Strategy for Eosinophilic Esophagitis
Corey J Ketchem, Uğurcan Vurgun, Agnes Wang, et al.
Page
of 64
Search research articles
Search
Showing results (501-510 of 635) with videos related to
Sort By:
Page
of 64
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 2, 2021
Reply
Ikuo Hirano, Margaret H Collins, David A Katzka, et al.
Gastrointestinal Endoscopy
|
September 20, 2021
Wide-area transepithelial sampling for dysplasia detection in Barrett's esophagus: a systematic review and meta-analysis
D Chamil Codipilly, Apoorva Krishna Chandar, Kenneth K Wang, et al.
Biotechnology Progress
|
September 3, 2014
Agrobacterium tumefaciens mediated transient expression of plant cell wall-degrading enzymes in detached sunflower leaves
Sang-Kyu Jung, Benjamin E Lindenmuth, Karen A McDonald, et al.
Gut
|
September 21, 2011
Association of insulin and insulin-like growth factors with Barrett's oesophagus
Katarina B Greer, Cheryl L Thompson, Lacie Brenner, et al.
Translational Oncology
|
February 19, 2010
Evidence for DNA damage checkpoint activation in barrett esophagus
Urs von Holzen, Tina Chen, Amelie Boquoi, et al.
The American Journal of Gastroenterology
|
September 28, 2000
CagA-positive strains of Helicobacter pylori may protect against Barrett's esophagus
M F Vaezi, G W Falk, R M Peek, et al.
Gut
|
February 6, 2015
Barrett's oesophagus length is established at the time of initial endoscopy and does not change over time: results from a large multicentre cohort
Fouad J Moawad, Patrick E Young, Srinivas Gaddam, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 15, 2025
Long-term Safety and Efficacy of Budesonide Oral Suspension for Eosinophilic Esophagitis: A 4-Year, Phase 3, Open-Label Study
Evan S Dellon, David A Katzka, Vincent A Mukkada, et al.
Therapeutic Advances in Gastroenterology
|
December 30, 2024
Effect of randomized treatment withdrawal of budesonide oral suspension on clinically relevant efficacy outcomes in patients with eosinophilic esophagitis: a post hoc analysis
Evan S Dellon, Margaret H Collins, David A Katzka, et al.
Gastro Hep Advances
|
May 28, 2026
Development and Validation of a Large Language Model Case Identification Strategy for Eosinophilic Esophagitis
Corey J Ketchem, Uğurcan Vurgun, Agnes Wang, et al.
Page
of 64